Intravenous Single Dose Toxicity of Sweet Bee Venom in Sprague-Dawley Rats
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Anaphylactic shock can be fatal to people who become hypersensitive when bee venom pharmacopuncture (BVP) is used. Thus, sweet bee venom (SBV) was developed to reduce these allergic responses. SBV is almost pure melittin, and SBV has been reported to have fewer allergic responses than BVP. BVP has been administered only into acupoints or intramuscularly, but we thought that intravenous injection might be possible if SBV were shown to be a safe medium. The aim of this study is to evaluate the intravenous injection toxicity of SBV through a single-dose test in Sprague-Dawley (SD) rats. Methods: Male and female 6-week-old SD rats were injected intravenously with SBV (high dosage: 1.0 mL/animal; medium dosage: 0.5 mL/animal; low dosage: 0.1 mL/animal). Normal saline was injected into the control group in a similar method. We conducted clinical observations, body weight measurements, and hematology, biochemistry, and histological observations. Results: No death was observed in any of the experimental groups. Hyperemia was observed in the high and the medium dosage groups on the injection day, but from next day, no general symptoms were observed in any of the experimental groups. No significant changes due to intravenous SBV injection were observed in the weights, in the hematology, biochemistry, and histological observations, and in the local tolerance tests. Conclusion: The results of this study confirm that the lethal dose of SBV is over 1.0 mL/animal in SD rats and that the intravenous injection of SBV is safe in SD rats.
Abstract
Objectives: Anaphylactic shock can be fatal to people who become hypersensitive when bee venom pharmacopuncture (BVP) is used. Thus, sweet bee venom (SBV) was developed to reduce these allergic responses. SBV is almost pure melittin, and SBV has been reported to have fewer allergic responses than BVP. BVP has been administered only into acupoints or intramuscularly, but we thought that intravenous injection might be possible if SBV were shown to be a safe medium. The aim of this study is to evaluate the intravenous injection toxicity of SBV through a single-dose test in Sprague-Dawley (SD) rats. Methods: Male and female 6-week-old SD rats were injected intravenously with SBV (high dosage: 1.0 mL/animal; medium dosage: 0.5 mL/animal; low dosage: 0.1 mL/animal). Normal saline was injected into the control group in a similar method. We conducted clinical observations, body weight measurements, and hematology, biochemistry, and histological observations. Results: No death was observed in any of the experimental groups. Hyperemia was observed in the high and the medium dosage groups on the injection day, but from next day, no general symptoms were observed in any of the experimental groups. No significant changes due to intravenous SBV injection were observed in the weights, in the hematology, biochemistry, and histological observations, and in the local tolerance tests. Conclusion: The results of this study confirm that the lethal dose of SBV is over 1.0 mL/animal in SD rats and that the intravenous injection of SBV is safe in SD rats.
참고문헌 (24)
- Korean Pharmacopuncture Institute, "Pharmacopuncturology: principles and clinical application", pp.147~179 (2012), Elsevier Korea LLC
- 이성노, "蜂藥鍼治療의 退行性膝關節炎에 대한 臨床的 考察", 대한침구의학회지, 20(5), pp.73~81 (2003), 대한침구의학회
- Wang WH, "Clincal investigation compared with the effects of the bee venom-acupuncture on knee joint with osteoarthritis", The Acupuncture, 18(3), pp.35~47 (2001)
- 권기록, "Three cases of affections of the hip treated with Korean Bee-Venom therapy", Journal of Pharmacopuncture, 4(3), pp.127~134 (2001), 대한약침학회[DOI]
- 이상훈, "봉독약침이 류마티스 관절염 환자의 관절 통증, 종창 및 급성 염증 반응에 미치는 영향", 대한침구의학회지, 20(2), pp.77~84 (2003), 대한침구의학회
- 김경운, "요추간판탈출증에 봉약침의 근위 취혈과 근위 및 원위 취혈의 비교", 대한침구의학회지, 22(6), pp.181~187 (2005), 대한침구의학회
- 이건목, "蜂藥鍼을 위주로 한 腰椎椎間板脫出症 의 突出型 患者(protrusion disc patients) 에 대한 臨床的 考察", 대한침구의학회지, 21(5), pp.13~26 (2004), 대한침구의학회
- 전형준, "봉약침으로 치료한 요추간판탈출증 환자의 임상적 평가", 대한침구의학회지, 20(5), pp.63~72 (2003), 대한침구의학회
- 이대용, "中風後遺症으로 인한 肩臂痛 患者의 蜂藥鍼治療에 대한 臨床的 考察", 대한침구의학회지, 23(4), pp.69~80 (2006), 대한침구의학회
- 권기록, "Sweet BV의 성분분석과 항체역가 및 allergy 반응에 대한 임상적 연구", Journal of Pharmacopuncture, 9(2), pp.79~86 (2006), 대한약침학회
- 최영권, "Gel filtration chromatography와 propionic acid", urea polyacrylamide gel electrophoresis를 이용한 봉독 성분의 분리, 2006, pp.9(2), 105~111[DOI]
- 이진선, "봉약침(Bee Venom)과 Sweet Bee Venom의 Allergy 반응에 대한 비교연구", Journal of Pharmacopuncture, 9(3), pp.61~77 (2006), 대한약침학회
- 권기록, "Sweet BV의 함량분석과 시술 부위별 LD50관찰", Journal of Pharmacopuncture, 10(2), pp.81~86 (2007), 대한약침학회
- 김영진, "Sweet BV의 rat를 이용한 단회 근육시술 독성시험", Journal of Pharmacopuncture, 12(4), pp.5~32 (2009), 대한약침학회
- 윤휘철, "Sweet Bee Venom의 비글견을 이용한 단회근육시술 독성시험", Journal of Pharmacopuncture, 13(4), pp.43~62 (2010), 대한약침학회
- 박재석, "Sweet Bee Venom의 비글견을 이용한 4주 반복 근육시술 독성시험", Journal of Pharmacopuncture, 13(4), pp.5~42 (2010), 대한약침학회
- 권혜연, "Sweet Bee Venom의 rat를 이용한 4주 반복 근육시술 독성시험", Journal of Pharmacopuncture, 14(1), pp.5~24 (2011), 대한약침학회
- 강현민, "Study of a 13-weeks, Repeated, Intramuscular Dose, Toxicity Test of Sweet Bee Venom in Sprague-Dawley Rats", Journal of Pharmacopuncture, 17(2), pp.73~79 (2014), 대한약침학회[DOI]
- 강현민, "Study on a 4-Week Recovery Test of Sweet Bee Venom after a 13-Week, Repeated, Intramuscular Dose Toxicity Test in Sprague-Dawley Rats", Journal of Pharmacopuncture, 17(2), pp.18~26 (2014), 대한약침학회[DOI]
- 이종영, "血脈에 대한 문헌적 고찰", Journal of Pharmacopuncture, 8(3), pp.11~19 (2005), 대한약침학회
- 강미숙, "≪黃帝內經․靈樞≫를 통한 血脈小考", 대한침구의학회지, 27(6), pp.111~114 (2010), 대한침구의학회
- 임청산, "Sweet BV의 침감비교 연구", Journal of Pharmacopuncture, 11(2), pp.55~62 (2008), 대한약침학회
- 안중철, "봉독과 Sweet Bee Venom의 항균 및 항산화능 비교연구", Journal of Pharmacopuncture, 9(3), pp.97~104 (2006), 대한약침학회
- 임청산, "Sweet BV가 복부 비만에 미치는 영향", Journal of Pharmacopuncture, 11(2), pp.33~40 (2008), 대한약침학회